BioMed Research International

MicroRNA and Cardiovascular Disease


Status
Published

Lead Editor

1Central South University, Changsha, China

2Stanford University, Stanford, USA

3Warsaw University of Life Sciences, Warsaw, Poland

4Chang Gung Memorial Hospital, Keelung, Taiwan


MicroRNA and Cardiovascular Disease

Description

Cardiovascular disease (CVD) is the leading cause of death and the most expensive health condition throughout the world, killing nearly 17 million people in 2011 around the world. During the past decade, there have been significant advances in our knowledge of the pathogenesis, diagnosis, and treatment in CVD. Recently, microRNAs (miRNAs) have emerged as being one of the most important gene regulators of widespread cellular function. However, we still do not have a complete understanding of the underlying mechanisms and pathological roles of miRNAs in cardiovascular tissue, whereas miRNAs represent a promising group of critical regulators of cardiovascular physiology and novel targets for prevention and treatment of CVD.

We sincerely invite researchers to contribute original research articles as well as review articles to this special issue, which will report the most recent results and progress about the involvement of miRNAs in CVD.

Potential topics include, but are not limited to:

  • miRNAs function in CVD
  • miRNAs as biomarkers of CVD
  • miRNAs as potential therapeutic targets of CVD
  • miRNAs expression changes after common pharmaceutical or surgical treatment for CVD
  • Bioinformatics study of microRNA in CVD

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 734380
  • - Editorial

MicroRNA and Cardiovascular Disease

Xiao-Bo Liao | Vinicio A. de Jesus Perez | ... | Ling-Qing Yuan
  • Special Issue
  • - Volume 2015
  • - Article ID 320849
  • - Review Article

The Role of Epigenetics in Arterial Calcification

Shan-Shan Wu | Xiao Lin | ... | Er-Yuan Liao
  • Special Issue
  • - Volume 2015
  • - Article ID 354517
  • - Review Article

Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling

Dmitry A. Chistiakov | Igor A. Sobenin | ... | Yuri V. Bobryshev
  • Special Issue
  • - Volume 2015
  • - Article ID 831641
  • - Review Article

MicroRNAs: Novel Players in Aortic Aneurysm

Xian-ming Fu | Yang-zhao Zhou | ... | Xin-min Zhou
  • Special Issue
  • - Volume 2015
  • - Article ID 732397
  • - Research Article

MicroRNA Clusters in the Adult Mouse Heart: Age-Associated Changes

Xiaomin Zhang | Gohar Azhar | ... | Jeanne Y. Wei
  • Special Issue
  • - Volume 2015
  • - Article ID 105620
  • - Review Article

Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease

Mario Notari | Julián Pulecio | Ángel Raya
  • Special Issue
  • - Volume 2015
  • - Article ID 391306
  • - Research Article

miR-27 and miR-125 Distinctly Regulate Muscle-Enriched Transcription Factors in Cardiac and Skeletal Myocytes

Estefania Lozano-Velasco | Jennifer Galiano-Torres | ... | Diego Franco
  • Special Issue
  • - Volume 2015
  • - Article ID 531740
  • - Review Article

MicroRNA-143/-145 in Cardiovascular Diseases

Wang Zhao | Shui-Ping Zhao | Yu-Hong Zhao
  • Special Issue
  • - Volume 2015
  • - Article ID 497280
  • - Research Article

miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress

Ana Mondadori dos Santos | Laurent Metzinger | ... | Valérie Metzinger-Le Meuth
  • Special Issue
  • - Volume 2015
  • - Article ID 624037
  • - Research Article

Runx2/miR-3960/miR-2861 Positive Feedback Loop Is Responsible for Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells

Zhu-Ying Xia | Yin Hu | ... | Hui Xie
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.